Pharmacokinetics and Pharmcodynamics Flashcards

1
Q

The drug’s effect on the body is called?

A

pharmacodynamics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pharmacodynamics includes:

A
therapeutic and toxic effects of drugs
  -sensitivity and responsiveness of receptors 
   (varies patient to patient)
  -mechanism of action
effective dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

a substance that binds to a specific receptor and triggers a response in the cell; mimics the action of an endogenous ligand that binds to the same receptor

A

agonist
(drug will probably have an increased effect of the same actions on receptors, ex: Sch has same effect as Ach but not metabolized as quickly so lasts longer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

effect not to the full degree

A

partial agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

causes maximal activation of all receptors

A

full agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

a drug that has affinity for the receptor, but no efficacy

A

antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the action of an antagonist

A

-does not activate the receptor to produce a physiologic action
-combination with receptor may block a response, so it does have a physiologic consequence
-typically has higher affinity for receptor than the agonist
(Narcan sometime higher affinity for opioid receptors and may even knock opioid off of receptor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the difference between competitive and noncompetitive antagonists?

A
  • competitive antagonists may be overwhelmed if enough agonist is built up and forces the antagonist off the receptor
  • noncompetitive antagonists bind to the receptor and does not come off; a new receptor must be generated allowing a longer effect since it takes time to synthesize a new receptor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the two types of antagonism?

A
  • physiologic antagonism: two agonist drugs bind to different receptors, causing opposing responses
  • ex: alpha1 agonist causes vasoconstriction, beta2 agonist causes vasodilation
  • chemical antagonism: no receptor activity involved; one drug binds with 2nd drug to inactivate it
  • ex: protamine binds with heparin eliminating anticoagulation effect but with no heparin, protamine is an anticoagulant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

possibly have both agonist and antagonist effects; activates a receptor, but cannot produce a maximum response (lower efficacy); may partially block effect of full agonists

A

partial agonist or agonist-antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

when are agonist-antagonist drugs commonly used

A
  • in labor and delivery since you don’t want the maximum opioid effect crossing the placenta
    ex: Nubain and Stadol act as agonists for some opioid receptors and antagonize others; antagonize MU-II opioid receptors to block respiratory depression but may have some effect on some MU-I receptors affecting analgesic effect of opioids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

component of a cell that interacts with a drug and initiates the chain of events leading to the drug’s effect

A

receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

describe receptors

A
  • can be extracellular and can go through from outside to inside
  • responsible for selectivity of drug action
  • mediate actions of both agonist and antagonists
  • affinity of receptor for a drug and the number of receptors may limit the maximal effect of a drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

the degree of drug receptor interaction for a given drug; the attraction between drug and receptor

A

affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

differentiates between different agonists that activate the same receptor, can all produce the same maximal response, but a differing concentrations

A

potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

a drug’s ability to produce the desired response expected by stimulation of a given receptor; the maximum effect that can be achieved with the drug
“intrinsic activity”

A

efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

explain the spare receptor concept.

A

maximal or nearly maximal response can often be produced by activation of only a fraction of the receptors present; relationship between the number of receptors stimulated and the response is usually nonlinear (an increased number of receptors stimulated does not mean an increase in response)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how does the spare receptor concept effect muscle receptors and antagonists?

A

It takes 70% of receptors blocked before reduction in muscle response is seen; showing that only 30% of the receptors must be activated by Ach to produce a maximal muscle response

  • it takes 90% of muscle receptors blocked by muscle relaxants for surgical relaxation
  • once decreased to only 70% blocked, considered fully recovered
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

desensitization with agonists; repeated use causes body to decrease the number of receptors and effect is diminished

A

down-regulation

  • tolerance
    ex: beta agonist bronchodilators (albuterol)- tolerance develops from repeated use and an increased dose is required for the same effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

chronic exposure to antagonists cause receptor number and sensitivity to increase

A

up-regulation

ex: beta blockers cause up regulation of receptors
* reason you don’t stop beta blockers before surgery; increase in receptors will lead to a major reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What factors affect pharmacologic response?

A

age, sex, weight, body surface area, basal metabolic rate, pathologic state, genetic profile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

the actions of the body on the drug

A

pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what are the stages of pharmacokinetics

A
  • absorption
  • distribution
  • metabolism
  • elimination of drugs and metabolites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is the first pass effect of absorption?

A

the liver extracts and or metabolizes the drug first before it goes to the site of action causing a lesser amount of drug getting to the site

  • reason for difference in effect of po and IV doses
  • po and rectal routes go through first pass effect
  • sublingual is absorbed directly into the superior vena cava
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what effects does ionized vs. nonionized have on distribution?

A
-ionized
 charged, water soluble
 not lipid soluble; do not cross the BBB
 *smaller distribution
-nonionized
 no charge; lipid soluble 
 *larger volume of distribution
 *cross lipid bilayers like BBB, GI, hepatocytes, renal 
  tubular and placenta
ex: muscle relaxants are water soluble, do not cross the BBB, so must give a sedative that can cross the BBB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

describe the Two Compartment Model.

A

A) 1st compartment: central compartment; plasma and vessel rich group (VRG); drug quickly hits high level in plasma and diffuses to VRG then other areas (redistribution phase)
2nd compartment: peripheral group (muscle group, lipid group, vessel poor group)
B) metabolism/clearance: begins to diffuse to other areas and must be metabolized and excreted (elimination phase)

27
Q

what is an example of the significance of the two compartment model?

A
  • propofol is administered IV and goes straight into plasma into systemic circulation
  • distributes to site of effect in CNS
  • when significant concentration builds up in CNS, plasma concentration has dropped
  • diffusion causes redistribution back into plasma
  • need to give anesthetic gas to keep sleep since propofol will start being metabolized and excreted. As excreted, drug stored in muscle lipid compartments begin to come back into plasma for excretion
28
Q

phase of two compartment model when the plasma concentration of the drug has declined to the point that the drug moves out of the vessel rich central group and is then taken into the peripheral group

A

redistribution (alpha) phase

29
Q

phase of two compartment model involves metabolism and excretion

A

elimination (beta) phase

30
Q

describe the vessel rich groups.

A

brain, heart, liver, kidney, endocrine

*receive 75% of CO but make up only 10% of body mass

31
Q

describe the lean muscle groups.

A

muscle and skin

*receives 19% of CO but make up 50% of body mass

32
Q

describe the fat group.

A

receives 6% of CO, make up 20% of body mass

33
Q

describe the vessel poor group.

A

bone, ligament, cartilage

*receives 0% of CO, make up 20% of body mass

34
Q

what’s the function of metabolism?

A

take lipid soluble materials and turn into water soluble to allow the kidneys to metabolize and excrete

35
Q

what are the four basic pathways of metabolism?

A
  • oxidation
  • reduction
  • hydrolysis
  • conjugation
36
Q

what are the two phases of metabolism?

A
  • Phase I: oxidation, reduction, and hydrolysis
  • increases the drug’s polarity, preparing it for phase II
  • Phase II: conjugation
  • drug (or metabolites if already gone through phase I) are linked to a highly ionized molecule making it more water soluble so it can be excreted
37
Q

what are sites of metabolism?

A
  • liver
  • plasma
  • lungs
  • kidneys
  • GI tract
38
Q

describe liver metabolism.

A
  • hepatic microsomal enzymes

- most metabolism occurs here

39
Q

describe plasma metabolism.

A
  • plasmaesterases are enzymes found in the plasma
  • Hoffmann elimination- organ independent metabolism affected by pH and temperature
  • pt in renal or liver failure can use the drugs metabolized here since it doesn’t affect any organs
40
Q

describe metabolism in the lungs.

A

some drugs are taken out of the body partly by the lungs including opioids, Inderal, and propanolol

41
Q

describe kidney metabolism.

A

eliminates unchanged drug

42
Q

describe GI tract metabolism.

A

NO2 metabolized by normal flora

43
Q

what are cytochrome P-450 enzymes?

A
  • phase I metabolism enzyme
  • one of the main metabolizing enzymes in the liver (hepatic microsomal enzymes)
  • uses oxidation
44
Q

what effects can drugs have on cytochrome P-450 enzymes?

A
  • some drugs induce enzymes, stimulating activity of cytochrome P-450 enzyme; significantly shorten duration of drugs due to increased metabolism
    ex: benzos, opioids, seizure meds (*Dilantin)
  • some drugs inhibit enzymes, slowing metabolism and causing drugs to have a prolonged effect
    ex: Tagamet
45
Q

what are non cytochrome P-450 enzymes of phase I metabolism?

A
  • plasma esterases and plasma cholinesterases
  • nonmicrosomal enzymes
  • metabolism by conjugation, hydrolysis, and some oxidation and reduction
  • present largely in the liver but also in GI tract and plasma (in plasma metabolism started before reaches site of action)
  • not inducible (cant rev up or inhibit)
  • activity is determined genetically
  • if deficiencies occur, can cause longer effects of these drugs allowing more of drug to get to the site of effect
46
Q

What are phase II enzymes?

A

-Glucoronosyltransferases
*propofol, morphine, versed
*infants unable to produce so usually avoid these drugs
-Glutathione-S-transferases
-N-acetyl-transferases
*some patients are either “fast” or “slow acetylators”
*protonix related drugs have complications with “fast
acetylators”
“slow acetylators” also have side effects
-sulfotransferases

47
Q

describe elimination or clearance

A
  • major sites: liver and kidneys
  • renal clearance: excretion of unchanged drug or its metabolites
  • in the liver, drug is metabolized or excreted unchanged in the bile, or both
  • important in determining the appropriate drug to administer to patients
48
Q

the time for the drug in the body to decrease by 50%; affected by volume of distribution and changes in clearance

A

Elimination 1/2 life

49
Q

the time for the plasma concentration of the drug to decrease to 50% during the elimination phase

A

Elimination 1/2 time

50
Q

time for the plasma drug concentration to decrease by 50% after discontinuing a continuous infusion of a specific duration

A

context-sensitive half-time

  • considers distribution, metabolism, and duration of infusion
  • typically, the longer the duration of the infusion, the longer the context-sensitive half-time
  • propofol and remifentanil special cases; both still metabolized quickly
51
Q

the half time of equilibrium between drug concentration in the blood and the drug effect; accounts for delay between IV injection into the plasma and the delivery of the drug to its site of action

A

effect-site equilibrium time

*important when considering redosing intervals

52
Q

how do you calculate the volume of distribution?

A

dose of drug given divided by the resulting plasma concentration prior to elimination

53
Q

what affects volume of distribution?

A
  • lipid solubility
  • binding to plasma proteins
  • molecular size
54
Q

how does protein binding affect volume of distribution?

A
  • plasma proteins
  • albumin-acidic drugs bind
  • alpha1 acid glycoprotein-basic drugs bind
  • only unbound drug can cross the cell membranes
  • increased binding leaves less effect
  • vd is inversely proportional to protein binding
  • elderly or alcoholics have less albumin, meaning less protein binding and greater drug effect
55
Q

combined effect of two drugs equal the expected sum of their individual actions
1+1=2

A

additive

56
Q

combined effect of two drugs is greater than the expected sum of their individual effects
1+1=3

A

synergistic

57
Q

action of one drug opposes the action of another

1+1=0

A

antagonistic

58
Q

the enhancement of the action of one drug by a second drug that has no detectable action of its own
1+0=3

A

potentiation

59
Q

very rapid development of tolerance, frequently with acute drug administration

A

tachyphylaxis

60
Q

abnormal or excessively sensitive, either psychologically or in physical response

A

hypersensitive

61
Q

showing a greater than normal response to stimuli

A

hyperreactive

62
Q

showing less than normal response to stimuli

A

hyporeactive

63
Q

an increasing concentration of drug is required to produce a given response

A

tolerance